Medical News

RSS

FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

St. Jude Medical, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its next-generation MultiSteering Technology software for Rapid Programmer™, a programming platform used to optimize neurostimulation therapy for chronic pain patients.

4 Dec 2009

CEBP journal emphasizes on the most up-to-date research of tobacco use

The study of tobacco has been the life-long focus of his research and now, Peter Shields, MD, deputy director of the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, has led the effort to edit a special-edition of Cancer Epidemiology, Biomarkers & Prevention (CEBP) dedicated to best research practices in tobacco science from researchers the world over.

4 Dec 2009

Minimally invasive spine surgery poised for rapid growth

Minimally invasive techniques have become standard for many procedures, from the removal of the gallbladder to angioplasty, but the approach is now only beginning to be available to patients with spinal conditions. The surgical team at NewYork-Presbyterian Hospital/Columbia University Medical Center's Spine Center aims to bring the benefits of minimally invasive surgery for patients with intractable back pain, stenosis, spinal deformity, even spinal cancer.

4 Dec 2009

PPA provides 'hopeful news' for patients struggling financially about paying for their medicines

The Redwood Gazette recently reported that there is "hopeful news" for patients who are struggling financially and worried about paying for their medicines. The Partnership for Prescription Assistance (PPA) has helped more than 6 million patients find programs providing prescription medicines for free or nearly free.

4 Dec 2009

Santaris Pharma's LNA technology based microRNA-targeted therapy holds promise for HCV

A study published online in this week's Science shows that SPC3649, a breakthrough microRNA-targeted therapy developed by Santaris Pharma A/S using its proprietary Locked Nucleic Acid (LNA) technology, holds promise as a novel treatment for patients infected with the Hepatitis C virus (HCV).

4 Dec 2009

CCI patients discharged from hospitals on ventilator support fare poorly four months later, says study

Patients, discharged from hospitals on ventilator support and with cognitive impairments, fare poorly four months later. Researchers from the Frances Payne Bolton School of Nursing at Case Western Reserve University report these findings in American Journal of Critical Care.

4 Dec 2009

Findings suggest severity of atherosclerosis depends on the rate of white blood cell migration

By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is important for the recruitment of white blood cells into the atherosclerotic plaque.

4 Dec 2009

PACS injection-record integration capabilities demonstrated at RSNA

Radiology imaging leader MEDRAD, Inc. demonstrated PACS injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago.

4 Dec 2009

Health leaders to discuss latest breast cancer findings at CTRC-AACR San Antonio Breast Cancer Symposium

Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal of eradicating breast cancer.

4 Dec 2009

CDEX felicitates recipients of the 2009 ASHP Literature Award for Pharmacy Practice Research

CDEX Inc. extends its congratulations to Dr. Jim Stevenson and members of his staff at the CS Mott Children's Hospital of the University of Michigan Health System, among the best in the nation, recipients of the 2009 ASHP Literature Award for Pharmacy Practice Research.

4 Dec 2009

RevMed introduces its proprietary suite of MRI software products at RSNA 2009

Revolutions Medical Corporation ("RevMed" or the "Company"), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that it introduced its proprietary suite of MRI software products at this week's Radiology Society of North America (RSNA) annual meeting with great success.

4 Dec 2009

InVivo Therapeutics files an Investigational Device Exemption application with the FDA

InVivo Therapeutics Corporation has filed an Investigational Device Exemption application with the Food and Drug Administration requesting permission to advance to human clinical studies. InVivo is currently conducting its third primate study and expects to receive approval to begin a human study in 2010.

4 Dec 2009

Adaptive vaccination strategies outperform seasonal influenza vaccination allocation strategies

Adaptive vaccination strategies, based on age patterns of hospitalizations and deaths monitored in real-time during the early stages of a pandemic, outperform seasonal influenza vaccination allocation strategies, according to findings reported Dec. 3 by researchers, including two from Arizona State University, in the online journal PLoS ONE.

4 Dec 2009

Personality characteristics can play a major role in determining successful medical career

Personality characteristics play a major role in determining who succeeds in medical school, according to new research published in the November issue of the Journal of Applied Psychology.

4 Dec 2009

Scientists discover mechanism by which E6 oncoprotein of high-risk HPV16 promotes carcinogenesis

In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to degenerate. It is known today that the main culprits are viral proteins E6 and E7. Both proteins switch off different cellular control functions, thus promoting cell growth.

4 Dec 2009

Viral Genetics to develop drug therapies for immune-related disorders and diseases

The University of Colorado and Viral Genetics Inc., recently executed an exclusive license agreement that expands on its previous agreement allowing Viral Genetics to develop treatments for autoimmune diseases, graft rejection, HIV, and cancer based on the work of M. Karen Newell, Ph.D., a professor of biology at the University of Colorado at Colorado Springs.

4 Dec 2009

Cancer-free status does not lead to resumption of smoking among former smokers

Assurance of a cancer-free status did not prompt people participating in a long-term computerized tomography (CT) lung-cancer screening program to pick up their cigarettes again, researchers wrote in a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

4 Dec 2009

StemCells welcomes NIH's approval of the first 13 human embryonic stem cell lines for research

StemCells, Inc. announced today that it welcomes the approval yesterday by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009.

4 Dec 2009

New evidence of a deep biological link between human music and speech

A pair of studies by Duke University neuroscientists shows powerful new evidence of a deep biological link between human music and speech.

4 Dec 2009

Neurologix completes Phase 2 clinical trial of Parkinson’s study

Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced the completion of all planned surgeries in an ongoing Phase 2 clinical trial of the company’s gene transfer approach to the treatment of advanced Parkinson’s disease.

4 Dec 2009

Medical News

FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

CEBP journal emphasizes on the most up-to-date research of tobacco use

Minimally invasive spine surgery poised for rapid growth

PPA provides 'hopeful news' for patients struggling financially about paying for their medicines

Santaris Pharma's LNA technology based microRNA-targeted therapy holds promise for HCV

CCI patients discharged from hospitals on ventilator support fare poorly four months later, says study

Findings suggest severity of atherosclerosis depends on the rate of white blood cell migration

PACS injection-record integration capabilities demonstrated at RSNA

Health leaders to discuss latest breast cancer findings at CTRC-AACR San Antonio Breast Cancer Symposium

CDEX felicitates recipients of the 2009 ASHP Literature Award for Pharmacy Practice Research

RevMed introduces its proprietary suite of MRI software products at RSNA 2009

InVivo Therapeutics files an Investigational Device Exemption application with the FDA

Adaptive vaccination strategies outperform seasonal influenza vaccination allocation strategies

Personality characteristics can play a major role in determining successful medical career

Scientists discover mechanism by which E6 oncoprotein of high-risk HPV16 promotes carcinogenesis

Viral Genetics to develop drug therapies for immune-related disorders and diseases

Cancer-free status does not lead to resumption of smoking among former smokers

StemCells welcomes NIH's approval of the first 13 human embryonic stem cell lines for research

New evidence of a deep biological link between human music and speech

Neurologix completes Phase 2 clinical trial of Parkinson’s study

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News